The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (97.41) USD. With the latest stock price at 0.57 USD, the upside of FibroGen Inc based on DCF is -17106.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 9.1% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (376.03) - (57.47) | (97.41) |
| Upside | -65747.8% - -10133.1% | -17106.2% |